The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia
- Authors:
- Prades R, Munarriz-Cuezva E, Urigüen L, Gil-Pisa I, Gómez L, Mendieta L, Royo S, Giralt E, Tarragó T, Meana JJ.
- Year:
- 2017
- Publication medium:
- European Neuropsychopharmacology
- Volume:
- 27
- Initial page - Ending page:
- 180 - 191